Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06906302 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

Study acronym: RISE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 12 of 12 entries
  2. Minor Site details revised at 1 of 3 sitesv4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 2025 to Sep 15, 2025
    • Site details revised at 3 of 3 sites
    v3
  4. Notable Start date: Jun 2025 to Sep 2025
    • Primary and study completion dates: Dec 2029 to Jan 2030
    • Secondary endpoints revised (12)
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
889 trials monitored
See 54 trials at risk
This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health. Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.
Trial Details
NCT Number NCT06906302
Lead Sponsor Boston University
Collaborators: VA Boston Healthcare System, VA Philadelphia Healthcare System, VA Minnesota Healthcare System, Patient-Centered Outcomes Research Institute
Conditions
(from sponsor)
Intimate Partner Violence (IPV)
Related terms Depression, Stress Disorders, Post-Traumatic
Enrollment 172 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov